查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590712

食物过敏诊断和治疗市场：按产品类型、技术、来源、成分和最终用户 - 2025-2030 年全球预测

Food Allergy Diagnostics & Therapeutics Market by Product Type (Diagnostic Tests Type, Therapeutic Treatment Type), Technology (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction), Source, Component, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年食物过敏诊断和治疗药物市场规模预计为58.6亿美元，预计2024年将达到64.3亿美元，复合年增长率为10.35%，2030年将达到116亿美元。

食物过敏诊断和治疗市场主要包括旨在识别和管理食物过敏的产品和服务，从诊断测试到治疗解决方案。这些技术的需求源于食物过敏的全球流行，它影响着数百万人的生活，需要准确的诊断和有效的治疗，以提高生活品质并降低医疗费用。应用范围从使用体外和分子过敏原诊断的临床环境到个人消费者的家庭检测套组。最终用途范围包括专门从事过敏和免疫学的医院、诊所和研究机构。关键的成长要素包括人们对食物过敏的认识提高、生物技术的进步以及研发投资的增加。最新的潜在机会在于开发新型生技药品、低过敏性食品和针对个人过敏原特征的个人化医疗方法。利用数位健康进步来进行病患教育和治疗依从性也是一个重要的成长途径。

主要市场统计
基准年[2023] 58.6亿美元
预测年份 [2024] 64.3亿美元
预测年份 [2030] 116.9亿美元
复合年增长率（%） 10.35%

然而，该市场面临一些限制，例如先进诊断测试的高成本、监管障碍以及食物过敏症状的变异性，使诊断和治疗的标准化变得复杂。另一个主要问题是由于缺乏意识和基础设施，发展中地区采用缓慢。为了促进创新，公司应该专注于开发具有成本效益的非侵入性诊断技术，加强食品过敏原标籤，并投资人工智慧和机器学习来预测过敏趋势和治疗效果。此外，与研究机构合作探索肠道微生物治疗方法可能会提供有希望的见解。儘管面临挑战，市场仍然充满活力，并以大量的研发活动和创新解决方案的稳定涌入为特征。随着对更准确诊断和有效治疗方法的需求增加，该行业已做好扩张的准备，而利用技术和战略伙伴关係关係的公司可能会获得竞争优势。

市场动态：快速发展的食物过敏诊断和治疗市场的关键市场洞察

由于供需的动态交互作用，食物过敏诊断和治疗药物市场正在经历转型。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 儿童和成人过敏性疾病增加
    • 组织增加对食物过敏诊断的资助
    • 患者对体外诊断血液检测的需求增加
  • 市场限制因素
    • 对食物过敏检测方法的认知度和实施率下降
  • 市场机会
    • 食物过敏诊断和治疗方法的技术不断进步
    • 增加药物开发的倡议
  • 市场挑战
    • 严格的食物过敏诊疗药物法规结构

波特五力：引领食物过敏诊断与治疗药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对食物过敏诊断和治疗药物市场的影响

外部宏观环境因素在塑造食物过敏诊断和治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解食物过敏诊断和治疗药物市场的竞争状况

食物过敏诊断和治疗市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在食物过敏诊断与治疗市场的绩效评估

FPNV定位矩阵是评估食物过敏诊断和治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划食物过敏诊断与治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，食物过敏诊断和治疗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 儿童和成人过敏性疾病的发生率增加
      • 组织增加对食物过敏诊断的资助
      • 患者对体外诊断血液检测的需求增加
    • 抑制因素
      • 食品过敏测试方法很少被认可并且很少实施。
    • 机会
      • 食物过敏诊断和治疗技术不断进步
      • 加大药物开发的研发力度
    • 任务
      • 严格的食物过敏诊断和治疗法规结构
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章食物过敏诊断与治疗药物市场：依产品类型

  • 诊断测试的类型
    • 体外
    • 体内/皮肤
      • 斑贴试验
      • 皮肤点刺试验
  • 治疗类型
    • 抗组织胺药
    • 肾上腺素自动注射器

第七章食物过敏诊断与治疗药物市场：依技术分类

  • 酵素免疫分析法
  • 聚合酵素链锁反应

第八章食物过敏诊断与治疗市场：依来源分类

  • 蛋
  • 鱼
  • 牛奶
  • 花生
  • 贝类
  • 大豆
  • 坚果
  • 小麦

第九章食物过敏诊断和治疗药物市场：按组成部分

  • 消耗品
  • 装置
  • 服务

第十章食物过敏诊断与治疗药物市场：依最终使用者分类

  • 学术研究所
  • 诊断实验室
  • 医院/诊所

第十一章北美和南美食物过敏诊断和治疗药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区食物过敏诊断及治疗药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲食物过敏诊断和治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Aleph Farm 透过收购 VBL Therapeutics 设施并与 ESCO Aster 合作提高产能
    • Jealous Pass Labs 在印度扩大过敏测试范围
    • Deeside公司取得食品过敏诊断美国专利
    • 「Thermo Fisher 小麦和芝麻过敏血液检测获得 FDA核准
    • CoreRx, Inc. 宣布 Aimmune Therapeutics 花生过敏治疗药物商业供应协议 - CoreRx(R)
    • Lantheus 宣布合作支持摄护腺癌的临床开发
    • Allergy Therapeutics 选择 AGC Biologics 生产花生过敏候选疫苗
    • FDA核准花生过敏候选药物的IND申请
    • Praetura Ventures主导对食品过敏诊断公司 290 万英镑的投资
    • Ukko 融资 4000 万美元，利用人工智慧解决食物过敏问题
  • 战略分析和建议

公司名单

  • 7 Drops Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • AESKU.GROUP GmbH
  • ALK-Abello A/S
  • Allergy Therapeutics PLC
  • Alpha Laboratories
  • Apexhealth by Acecgt Diagnostic Limited
  • Apollo Diagnostics
  • Aster Clinical Lab LLP
  • Astra Biotech GmbH
  • bioMerieux SA
  • Cerascreen GmbH
  • Eurofins Scientific（Ireland）Limited
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HollisterStier Allergy by Jubilant Pharma Holdings Inc.
  • HYCOR Biomedical
  • Indoor Biotechnologies, Inc.
  • Laboratory Corporation of America Holdings.
  • Lincoln Diagnostics, Inc.
  • Medeca Pharma AB
  • Microbac Laboratories, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporatio
  • Nestle Health Science
  • Omega Diagnostics Group PLC
  • Prota Therapeutics Pty. Ltd.
  • Quest Consumer Inc.
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH
  • ROXALL Medizin GmbH
  • Siemens AG
  • STALLERGENES GREER International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-ED54C46E8118

The Food Allergy Diagnostics & Therapeutics Market was valued at USD 5.86 billion in 2023, expected to reach USD 6.43 billion in 2024, and is projected to grow at a CAGR of 10.35%, to USD 11.69 billion by 2030.

The food allergy diagnostics and therapeutics market primarily encompasses products and services aimed at identifying and managing food allergies, from diagnostic tests to therapeutic solutions. The necessity for these technologies arises from a growing prevalence of food allergies globally, impacting millions of lives and necessitating accurate diagnostics and effective treatments to enhance quality of life and reduce healthcare costs. Applications range from clinical settings, where in vitro and molecular allergen diagnostics are used, to at-home testing kits for individual consumer use. The end-use scope includes hospitals, clinics, and research institutions focused on allergy and immunology. Key growth influencers include rising awareness of food allergies, advancements in biotechnology, and increasing investments in research and development. The latest potential opportunities lie in the development of novel biologics, hypoallergenic food products, and personalized medicine approaches tailored to individual allergen profiles. Exploiting advancements in digital health for patient education and adherence to therapies also presents substantial growth avenues.

KEY MARKET STATISTICS
Base Year [2023] USD 5.86 billion
Estimated Year [2024] USD 6.43 billion
Forecast Year [2030] USD 11.69 billion
CAGR (%) 10.35%

However, the market faces limitations such as high costs of advanced diagnostic tests, regulatory hurdles, and variability in food allergy manifestations that complicate standardization in diagnostics and treatment. Slow adoption in developing regions due to lack of awareness and infrastructure also poses significant challenges. To foster innovation, businesses can focus on developing cost-effective, non-invasive diagnostic technologies, enhancing food allergen labeling, and investing in AI and machine learning to predict allergy trends and treatment effectiveness. Additionally, collaboration with research institutions to explore gut microbiome therapies could offer promising insights. Despite its challenges, the market is dynamic, marked by significant research and development activities and a steady influx of innovative solutions. As the demand for more precise diagnosis and effective therapeutics grows, the industry is poised for expansion, with companies that leverage technology and strategic partnerships likely to gain a competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Food Allergy Diagnostics & Therapeutics Market

The Food Allergy Diagnostics & Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of allergic conditions among pediatric and adult populations
    • Increasing funds by organizations in food allergy diagnostics
    • Rising patient demand for in vitro diagnostic blood tests
  • Market Restraints
    • Limited awareness and less implementation of food allergic testing methods
  • Market Opportunities
    • Ongoing technological advancements in food allergy diagnostics and therapeutics
    • Increasing number of research and development initiatives for the development of drugs
  • Market Challenges
    • Stringent regulatory framework for food allergy diagnostics and therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Food Allergy Diagnostics & Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Food Allergy Diagnostics & Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Food Allergy Diagnostics & Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Food Allergy Diagnostics & Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Food Allergy Diagnostics & Therapeutics Market

A detailed market share analysis in the Food Allergy Diagnostics & Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Food Allergy Diagnostics & Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Food Allergy Diagnostics & Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Food Allergy Diagnostics & Therapeutics Market

A strategic analysis of the Food Allergy Diagnostics & Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abello A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMerieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestle Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostic Tests Type and Therapeutic Treatment Type. The Diagnostic Tests Type is further studied across In Vitro and In Vivo/Skin. The In Vivo/Skin is further studied across Patch Test and Skin Prick Test. The Therapeutic Treatment Type is further studied across Antihistamines and Epinephrine Auto-Injector.
  • Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay and Polymerase Chain Reaction.
  • Based on Source, market is studied across Eggs, Fish, Milk, Peanuts, Shellfish, Soy, Tree Nuts, and Wheat.
  • Based on Component, market is studied across Consumables, Instruments, and Services.
  • Based on End-User, market is studied across Academic Research Institutes, Diagnostics Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of allergic conditions among pediatric and adult populations
      • 5.1.1.2. Increasing funds by organizations in food allergy diagnostics
      • 5.1.1.3. Rising patient demand for in vitro diagnostic blood tests
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and less implementation of food allergic testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in food allergy diagnostics and therapeutics
      • 5.1.3.2. Increasing number of research and development initiatives for the development of drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework for food allergy diagnostics and therapeutics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Food Allergy Diagnostics & Therapeutics Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostic Tests Type
    • 6.2.1. In Vitro
    • 6.2.2. In Vivo/Skin
      • 6.2.2.1. Patch Test
      • 6.2.2.2. Skin Prick Test
  • 6.3. Therapeutic Treatment Type
    • 6.3.1. Antihistamines
    • 6.3.2. Epinephrine Auto-Injector

7. Food Allergy Diagnostics & Therapeutics Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Polymerase Chain Reaction

8. Food Allergy Diagnostics & Therapeutics Market, by Source

  • 8.1. Introduction
  • 8.2. Eggs
  • 8.3. Fish
  • 8.4. Milk
  • 8.5. Peanuts
  • 8.6. Shellfish
  • 8.7. Soy
  • 8.8. Tree Nuts
  • 8.9. Wheat

9. Food Allergy Diagnostics & Therapeutics Market, by Component

  • 9.1. Introduction
  • 9.2. Consumables
  • 9.3. Instruments
  • 9.4. Services

10. Food Allergy Diagnostics & Therapeutics Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Research Institutes
  • 10.3. Diagnostics Laboratories
  • 10.4. Hospitals & Clinics

11. Americas Food Allergy Diagnostics & Therapeutics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Food Allergy Diagnostics & Therapeutics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Food Allergy Diagnostics & Therapeutics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Aleph Farms Increases Production Capabilities With VBL Therapeutics Facility Acquisition And ESCO Aster Partnership
    • 14.3.2. Jerath Path Labs expands the reach in India in allergy-testing
    • 14.3.3. Deeside firm secures US patent for food allergy diagnostics
    • 14.3.4. "Thermo Fisher's Wheat And Sesame Allergy Blood Tests Earn FDA Nod
    • 14.3.5. CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics' Investigational Peanut Allergy Treatment - CoreRx(R)
    • 14.3.6. Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
    • 14.3.7. Allergy Therapeutics Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate
    • 14.3.8. FDA approves IND application for peanut allergy drug candidate
    • 14.3.9. Praetura Ventures leads £2.9m investment in food allergy diagnostic company
    • 14.3.10. Ukko raises $40 million to address food allergies with AI
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 7 Drops Diagnostics, Inc.
  • 2. ACON Laboratories, Inc.
  • 3. AESKU.GROUP GmbH
  • 4. ALK-Abello A/S
  • 5. Allergy Therapeutics PLC
  • 6. Alpha Laboratories
  • 7. Apexhealth by Acecgt Diagnostic Limited
  • 8. Apollo Diagnostics
  • 9. Aster Clinical Lab LLP
  • 10. Astra Biotech GmbH
  • 11. bioMerieux SA
  • 12. Cerascreen GmbH
  • 13. Eurofins Scientific (Ireland) Limited
  • 14. EUROIMMUN Medizinische Labordiagnostika AG
  • 15. HollisterStier Allergy by Jubilant Pharma Holdings Inc.
  • 16. HYCOR Biomedical
  • 17. Indoor Biotechnologies, Inc.
  • 18. Laboratory Corporation of America Holdings.
  • 19. Lincoln Diagnostics, Inc.
  • 20. Medeca Pharma AB
  • 21. Microbac Laboratories, Inc.
  • 22. Minaris Medical America, Inc.
  • 23. Neogen Corporatio
  • 24. Nestle Health Science
  • 25. Omega Diagnostics Group PLC
  • 26. Prota Therapeutics Pty. Ltd.
  • 27. Quest Consumer Inc.
  • 28. R-Biopharm AG
  • 29. Romer Labs Division Holding GmbH
  • 30. ROXALL Medizin GmbH
  • 31. Siemens AG
  • 32. STALLERGENES GREER International AG
  • 33. Tecan Trading AG
  • 34. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PATCH TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SKIN PRICK TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY EPINEPHRINE AUTO-INJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY EGGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MILK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PEANUTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SHELLFISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TREE NUTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY WHEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-203